Patents by Inventor PANAGIOTIS DIAMANTAKOS

PANAGIOTIS DIAMANTAKOS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220125869
    Abstract: The present invention relates to the method for obtaining in pure form or as a mixture of the bioactive diol forms of the main secoiridoid phenols present in olive oil and certain isomeric forms or derivatives thereof. Specifically, it relates to the production process of S-(E)-oleocanthadiol, S-(E)-oleaceinediol, 5S-(E)-oleomissionadiol, 5S-(E)-oleokoronadiol, oleuropeinediol and ligstrodiol and their corresponding polyethylene glycol hemiacetals through extraction of specifically selected olive oil with polyethylene glycol and then treated with water. It also relates to the pharmaceutical preparations containing the above substances in various combinations and the therapeutic properties of these preparations for the treatment of cancer, degenerative diseases of the central nervous system, diabetes, hyperlipidemia, inflammatory diseases and the prevention of creation of atherosclerotic plaques and thrombi.
    Type: Application
    Filed: February 11, 2020
    Publication date: April 28, 2022
    Applicant: OMPHAX SA
    Inventors: PROKOPIOS MAGIATIS, ELENI MELLIOU, PANAGIOTIS DIAMANTAKOS, AIMILIA RIGAKOU
  • Publication number: 20220119335
    Abstract: The present invention relates to a method for obtaining in pure form or in a mixture the oleacein and oleomissional substances from olive fruits and leaves and certain derivatives thereof, the bioactive diol forms, by selective extraction of specially selected leaves or fruits with water or organic solvents. It also relates to pharmaceutical preparations containing the above substances in various combinations and the therapeutic properties of these preparations for the treatment of cancer, degenerative diseases of the central nervous system, diabetes, hyperlipidemia, inflammatory diseases and the prevention of creation of atherosclerotic plaques and thrombi.
    Type: Application
    Filed: February 11, 2020
    Publication date: April 21, 2022
    Applicant: OMPHAX SA
    Inventors: PROKOPIOS MAGIATIS, ELENI MELLIOU, PANAGIOTIS DIAMANTAKOS, AIMILIA RIGAKOU